Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Citatah Tbk. (CTTH) vs Millennium Pharmacon International Tbk. (SDPC)

Citatah Tbk.Trading
Millennium Pharmacon International Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Citatah Tbk. dan Millennium Pharmacon International Tbk.: Citatah Tbk. diperdagangkan di Rp109 (kapitalisasi pasar 136,62 M, volume 24 jam 3,38 jt), sedangkan Millennium Pharmacon International Tbk. diperdagangkan di Rp181 (kapitalisasi pasar 230,59 M, volume 24 jam 12,1 rb). Perbedaan utamanya: Millennium Pharmacon International Tbk. lebih besar dari sisi kapitalisasi pasar, dan Citatah Tbk. lebih aktif diperdagangkan (3,38 jt vs 12,1 rb). Mana yang lebih baik tergantung tujuan investasimu.

CTTHSDPC
Kapitalisasi Pasar
136,62 M230,59 M
Volume
3,38 jt12,1 rb
Lot
33,83 rb121
Perputaran
370,83 jt2,2 jt
Harga Rata-rata
109,63181,48
Nilai Transaksi
370,83 jt2,2 jt
Harga Ekuilibrium Indikatif
109
Volume Ekuilibrium Indikatif
1,66 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

CTTH
Lihat detail
SDPC
Lihat detail

Tentang Citatah Tbk.

Citatah was the first private company to develop Indonesia’s marble resources, and has been involved in the extraction and processing of marble for twenty five years. Established in 1974, the company began mining began mining beige marble from its quarry near Bandung, and subsequently achieved a dominant market position for its material in Indonesia. In January 1996, the company acquired a 90% shareholding in PT Quarindah Ekamaju Marmer, a marble company with quarries and a modern processing plant in Singkep, South Sulawesi. Soon after, Citatah acquired a license to mine an additional quarry at Pingkep, which increased the company’s potential raw material output to 60,000 cubic meters a year. In 1998, Citatah opened its Special Projects Centre at Karawang, East of Jakarta. This processing facility comprises a marble and granite slab cutting and polishing factory alongside a design and fabrication factory, which houses a variety of specialist cutting, shaping and finishing machinery. The special projects center is considered to be one of the most modern and complete stone fabrication factories in the world. In 1999, Citatah began excavation at a 50 hectare quarry site in West Timur. This new quarry produces a unique and attractive beige marble which will become the company’s principal export product for the new millennium. Work has already begun on the necessary infrastructure to fully develop the quarry site.  An international sales network of agents and representatives supports Citatah’s production, and a majority owned sales subsidiary, UGMC Inc., in California, USA. In 1999, three quarters of the company’s production was exported, mainly to markets in the Asia Pacific region and the US, an overseas revenues accounted for over 90% of Total Sales, and in 2000, 75% of Total Sales.

Selengkapnya di halaman CTTH

Tentang Millennium Pharmacon International Tbk.

PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.

Selengkapnya di halaman SDPC